What precisely is the melanotan?

Melanotan was developed from a drug called afamelanotide, which was first synthesised at the University of Arizona in 1981 with the intention of serving as a photoprotectant against the harmful effects of the sun. This medicine is currently being evaluated in clinical trials for use in patients suffering from specific sun-sensitive skin diseases. It is not currently available for purchase by the general public.

The medication is connected to the alpha-melanocyte stimulating hormone (-MSH) biologically, and it attaches to receptors in human skin cells that are called melanocortin receptors. This binding to the -MSH receptor, which plays a crucial role in the establishment of skin and also hair pigmentation, causes an increase in the synthesis of melanin in the skin, which results in the appearance of a “sun tan.”

Melanotan is a synthetic analogue of -MSH. It is now being marketed online for self-administration despite the fact that it is illegal, that it has not been tested, and that it is not controlled. The creation of -MSH is extremely delicate and calls for a comprehensive production setting, neither of which can be assured in unregulated production facilities. In addition to that, the item has to be stored in a refrigerator.

What exactly is the main difference between Melanotan I and Melanotan II?

Melanotan I specifically binds to the receptors that are responsible for tanning; as a result, it has less adverse effects. However, because a greater quantity of it is necessary for an effect, the cost of Melanotan III is significantly more than that of Melanotan II.

Melanotan II has greater adverse effects than other tanning agents since it attaches to receptors in addition to those that are responsible for tanning.

What are the potential negative effects?

Due to the fact that this medication has not only been tested but also controlled, the whole list of potential adverse effects is unknown. It has been reported that individuals have had increased sex desire, spontaneous erections, nausea (which was followed by weight management), face flushing when on management, flu-like signs and symptoms, and elevated high blood pressure.

Just what are the sources of melanotan?

Subcutaneous administration of melanotan involves injecting the medication into the fatty layer of tissue that surrounds the resistant belly button location. Customers inject themselves on a daily basis until they acquire the colour they want, and then they continue to inject themselves once or twice a week to maintain the colour.

It is possible that the injection alone will cause a slight lightening of the skin, but the results will be much more noticeable if the injection is combined with exposure to ultraviolet light (from the sun or a tanning bed), initially between two and three times per week and then between one and two times per week after that.

How precisely is Melanotan distributed?

Products such as the following can be found on the market:

Main problems

Both the substance and the purity of the product:


Unknown adverse consequences include:


Infusing equipment


Disposal of discarded needles and other sharps

There is evidence that needles have been discarded in the trash at residential locations.

Increased direct exposure to ultraviolet radiation

Because the effects of the tanning agents are more noticeable when used in conjunction with exposure to UV light (whether through natural sunlight or through tanning beds), the use of the tanning agents may increase UV exposure, along with all of the enhancement risks associated with that, such as an increased risk of skin cancerous cells, age spots, and so on.

Activities that reduce damage


In the event that you are utilising Clean infusing tools:


Safe disposal.

Additionally, the kit comes with a compact sharps container for storing spent sharps. Used sharps can be returned to pharmacies for disposal as long as they are placed in the appropriate sharps container.

Contamination of the product as well as its instability.

On the internet, you can find products that are either not licenced, not tested, or fraudulently sold under the name “melanotan II.” These products are purported to be effective as “tanning drugs,” despite the fact that they have been linked to a number of adverse effects, including uneven pigmentation (it helps make already uneven colouration more noticeable), the development of new nevi (moles), and the darkening or enlargement of preexisting moles. As a result, medical authorities have There has been no research conducted in a scientific setting on the potential long-term and irreversible consequences of using this peptide.